Steven Frank
CIK: 0001583886
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 31, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.3K shares at avg. $9.70$12K - Jun 11, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct15.3K shares- - May 29, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.3K shares at avg. $8.91$11K - Mar 13, 2026PGEN
PRECIGEN, INC.
Exercise(M)Direct71.8K shares- - Mar 10, 2026PGEN
PRECIGEN, INC.
Award(A)Direct14.2K shares at avg. $3.51$50K - Feb 27, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.3K shares at avg. $8.75$11K - Nov 28, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.6K shares at avg. $7.18$11K - Aug 29, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.4K shares at avg. $8.31$11K - Jun 12, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct12.5K shares- - May 30, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct333 shares at avg. $10.75$4K - May 2, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct1.9K shares- - Mar 14, 2025PGEN
PRECIGEN, INC.
Exercise(M)Direct87.4K shares- - Mar 13, 2025PGEN
PRECIGEN, INC.
Award(A)Direct28.7K shares at avg. $1.74$50K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,288 | $9.70 | $12,494 | Direct |
| Jun 11, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 15,294 | - | $0 | Direct |
| May 29, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,262 | $8.91 | $11,244 | Direct |
| Mar 13, 2026 |  PGEN PRECIGEN, INC. | Exercise(M) | 71,839 | - | $0 | Direct |
| Mar 10, 2026 | PGEN PRECIGEN, INC. | Award(A) | 14,245 | $3.51 | $50,000 | Direct |
| Feb 27, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,285 | $8.75 | $11,244 | Direct |
| Nov 28, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,566 | $7.18 | $11,244 | Direct |
| Aug 29, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,353 | $8.31 | $11,243 | Direct |
| Jun 12, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 12,500 | - | - | Direct |
| May 30, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 333 | $10.75 | $3,580 | Direct |
| May 2, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 1,866 | - | - | Direct |
| Mar 14, 2025 | PGEN PRECIGEN, INC. | Exercise(M) | 87,412 | - | - | Direct |
| Mar 13, 2025 | PGEN PRECIGEN, INC. | Award(A) | 28,735 | $1.74 | $49,999 | Direct |
1-13 of 13 transactions
About Frank Steven
Frank Steven (SEC CIK 0001583886) files insider reports with the SEC as Director of BIOCRYST PHARMACEUTICALS INC (BCRX) and Director of PRECIGEN, INC. (PGEN).
Signal8 holds 13 ownership filings by Frank Steven (1 Form 3, 12 Form 4), filed between Mar 17, 2025 and Sep 2, 2026. Those filings report 13 transactions, from Mar 13, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Frank Steven's filings is in DURHAM, NC.
Recent filings by Frank Steven
- Aug 31, 2026: Grant or award of BCRX shares (Form 4, code A).
- Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
- May 29, 2026: Grant or award of BCRX shares (Form 4, code A).
- Mar 13, 2026: Option exercise of PGEN shares (Form 4, code M).
- Mar 10, 2026: Grant or award of PGEN shares (Form 4, code A).
Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)
- Stonehouse Jon P, Director
- Milne Jill C., Director
- MILANO VINCENT, Director
- McKee Amy E, Director
- Galson Steven K, Director
- LEVIN ALAN G, Director